Shan Liu

2.2k citations
85 papers · 1.5k indexed · h-index 23
Topics
Extracellular vesicles in disease (8 papers)MicroRNA in disease regulation (7 papers)Circular RNAs in diseases (5 papers)

In The Last Decade

Shan Liu

80 papers receiving 1.5k citations

Peers

Shan Liu
Comparison fields: 5 of 154
  • Molecular Biology 583
  • Cancer Research 274
  • Immunology 179
  • Biomedical Engineering 159
  • Epidemiology 121
Replace Jiyoon Kim with:
Jiyoon Kim South Korea
Chao Yan China
Bo Yu China
Jiancheng Wang China
Hui‐Ching Tseng Taiwan
Mingyue Wang China
Wenjing Jin China
R. Scott United States
Chunhong Li China
Hee‐Jun Kim South Korea
Shan Liu relative to Jiyoon Kim South Korea Jiyoon Kim's profile →
Citations per field
00.5×1.6×
Jiyoon Kim · 1×
Citations per year

Countries citing papers authored by Shan Liu

Since Specialization
Citations

This map shows the geographic impact of Shan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Liu more than expected).

Fields of papers citing papers by Shan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Liu. The network helps show where Shan Liu may publish in the future.

Co-authorship network of co-authors of Shan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Liu. A scholar is included among the top collaborators of Shan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Liu. Shan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 6
3 19
4 7
5 6
6 1
7 26
8 6
9
Rapid determination of N-dimethyl nitrosamine in beer by salt-assisted dispersible liquid-liquid microextraction combined with gas chromatography-tandem mass spectrometry.
1
10 35
11 50
12 91
13 14
14 37
15 10
16 25
17 39
18 28
19 25
20
Fuzzy comprehensive assessment of highway construction project impacts on environment
1

About Shan Liu

Shan Liu is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Cell Biology, having authored 85 papers that have together received 1.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (583 citations) and Immunology (179 citations). Shan Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jinlong Zhang, Mark Keil, Tao Chen, Haipeng Liu, Jun Li, Yanlian Li, Max Costa, Bo Ning, Christopher J. Lyon and Tiannan Wei. Their work appears in journals such as Advanced Materials, PLoS ONE and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026